Patents Assigned to Laboratoire Biodim
  • Patent number: 9604900
    Abstract: The present invention relates to aromatic carbocycle or heterocycle compounds comprising an acid function and being of formula (5), wherein W, Q1, Q2, Q3, Q4, R1, R3, R4, R7, R9, R11, a, c, e, and g are as described in the description; and the use of such compounds in the treatment or the prevention of viral disorders, including HIV.
    Type: Grant
    Filed: April 13, 2012
    Date of Patent: March 28, 2017
    Assignee: LABORATOIRE BIODIM
    Inventors: Sophie Chasset, Francis Chevreuil, Benoit Ledoussal, Frédéric Le Strat, Richard Benarous
  • Patent number: 9562033
    Abstract: The present invention relates to compounds, their use in the treatment or the prevention of viral disorders, including HIV.
    Type: Grant
    Filed: October 7, 2013
    Date of Patent: February 7, 2017
    Assignee: LABORATOIRE BIODIM
    Inventors: Richard Benarous, Francis Chevreuil, Benoit Ledoussal, Sophie Chasset, Frédéric Le Strat
  • Patent number: 9475802
    Abstract: Inhibitors of viral replication of formula (I), their process of preparation and their therapeutical uses. The present invention relates to compounds, their use in the treatment or the prevention of viral disorders, including HIV.
    Type: Grant
    Filed: October 11, 2013
    Date of Patent: October 25, 2016
    Assignee: LABORATOIRE BIODIM
    Inventors: Richard Benarous, Francis Chevreuil, Benoit Ledoussal, Sophie Chasset, Frédéric Le Strat
  • Publication number: 20160152543
    Abstract: The present invention relates to compounds, their use in the treatment or the prevention of viral disorders, including HIV.
    Type: Application
    Filed: July 7, 2014
    Publication date: June 2, 2016
    Applicant: LABORATOIRE BIODIM
    Inventors: Benoit LEDOUSSAL, Frédéric LE STRAT, Sophie CHASSET, Julien BARBION, Julie BRIAS, Audrey CARAVANO, Fabien FAIVRE, Sophie VOMSCHEID
  • Patent number: 9260395
    Abstract: The present invention relates to compounds of formula (I), their the treatment or the prevention of viral disorders, including HIV.
    Type: Grant
    Filed: October 7, 2013
    Date of Patent: February 16, 2016
    Assignee: LABORATOIRE BIODIM
    Inventors: Richard Benarous, Francis Chevreuil, Benoit Ledoussal, Sophie Chasset, Frédéric Le Strat
  • Patent number: 9238026
    Abstract: The present invention relates to compounds, their use in the treatment or the prevention of viral disorders, including HIV.
    Type: Grant
    Filed: April 6, 2012
    Date of Patent: January 19, 2016
    Assignee: LABORATOIRE BIODIM
    Inventors: Sophie Chasset, Francis Chevreuil, Benoit Ledoussal, Frédéric Le Strat, Richard Benarous
  • Publication number: 20150291636
    Abstract: The invention relates to compounds of formulae (Ia), (Ib) or (Ic) wherein, A1 and A2, identical or different, are H, (C1-C6) alkyl, (C1-C6) fluoroalkyl, (C2-C6) alkenyl, (C2-C6) alkynyl, (C1-C6) alkyl-ORa, (C1-C6) alkyl-SRa, (C1-C6) alkyl-NRaRb, ORa, SRa, NRaRb, or CORa; A3 is H, OH or form a carbonyl with A4; A4 is H, OH or form a carbonyl with A3; A5 is H, CRaRbOH, F, OH or forms a double bond with X in the case where X is CH; A6 is H or F; X is CH2, CHF, CF2, CHOH, O, S, NRa or a simple bond, or X is CH in the case where A5 forms with X a double bond; Y is P(O)(ORa)(ORb) or P(O)(ORa)(NRaRb); V is O or S; A7 is H, (C1-C6) alkyl, (C1-C6) fluoroalkyl, (C2-C6) alkenyl, (C2-C6) alkynyl or (C1-C6) alkyl-ORa; A8 is OH or H, Ra and Rb, identical or different, are H, (C1-C6) alkyl, (C1-C6) fluoroalkyl, (C1-C6) alkyl-OH or (C1-C6) alkyl-O—(C1-C6) alkyl; and their addition salts thereof with acids and bases, their preparation and their use in the antibacterial prevention and therapy, used alone or in association with
    Type: Application
    Filed: October 28, 2013
    Publication date: October 15, 2015
    Applicant: LABORATOIRE BIODIM
    Inventors: Dmytro Atamanyuk, Vincent Gerusz, Francois Moreau, Vivien Henryon, Jerome Monbrun, Etienne Airiau
  • Publication number: 20150274718
    Abstract: Inhibitors of viral replication of formula (I), their process of preparation and their therapeutical uses. The present invention relates to compounds, their use in the treatment or the prevention of viral disorders, including HIV.
    Type: Application
    Filed: October 11, 2013
    Publication date: October 1, 2015
    Applicant: LABORATOIRE BIODIM
    Inventors: Richard Benarous, Francis Chevreuil, Benoit Ledoussal, Sophie Chasset, Frédéric Le Strat
  • Publication number: 20140128383
    Abstract: The present invention relates to compounds, their use in the treatment or the prevention of viral disorders, including HIV.
    Type: Application
    Filed: April 6, 2012
    Publication date: May 8, 2014
    Applicant: LABORATOIRE BIODIM
    Inventors: Sophie Chasset, Francis Chevreuil, Benoit Ledoussal, Frédéric Le Strat, Richard Benarous
  • Publication number: 20140031338
    Abstract: The present invention relates to compounds, their use in the treatment or the prevention of viral disorders, including HIV.
    Type: Application
    Filed: April 13, 2012
    Publication date: January 30, 2014
    Applicant: LABORATOIRE BIODIM
    Inventors: Sophie Chasset, Francis Chevreuil, Benoit Ledoussal, Frédéric Le Strat, Richard Benarous
  • Publication number: 20140024576
    Abstract: Compounds having the general formula (I) pharmaceutical compositions containing them for use in inhibiting bacterial heptose biosynthesis and thereby lowering or suppressing bacterial virulence.
    Type: Application
    Filed: December 1, 2011
    Publication date: January 23, 2014
    Applicant: LABORATOIRE BIODIM
    Inventors: Vincent Gerusz, Stéphane Vincent, Mayalen Oxoby, Dmytro Atamanyuk, François Moreau, Mounir Andaloussi, Abdellatif Tikad
  • Patent number: 8513250
    Abstract: The invention relates to Imidazolo-heteroaryl derivatives of formula (I). The compounds inhibit the activity of the Dlta enzyme of Gram-positive bacteria and are useful to treat Gram-positive bacterial infections. Furthermore the application discloses method for assessing the Dlta inhibitory activity of tested molecules and a method for measuring the efficacy of molecules in inhibiting bacteria proliferation in vitro.
    Type: Grant
    Filed: March 21, 2008
    Date of Patent: August 20, 2013
    Assignee: Laboratoire Biodim
    Inventors: Sonia Escaich, Alexis Denis, Vincent Gerusz, François Moreau, Mayalen Oxoby, Yannick Bonvin
  • Patent number: 8197821
    Abstract: The present invention relates to protein-protein interactions involved in AIDS. More specifically, the present invention relates to complexes of polypeptides or polynucleotides encoding the polypeptides, fragments of the polypeptides, antibodies to the complexes, Selected Interacting Domains (SID®) which are identified due to the protein-protein interactions, methods for screening drugs for agents which modulate the interaction of proteins and pharmaceutical compositions that are capable of modulating the protein-protein interactions.
    Type: Grant
    Filed: February 25, 2008
    Date of Patent: June 12, 2012
    Assignee: Laboratoire Biodim
    Inventors: Pierre Legrain, Jean-Christophe Rain, Richard Benarous, Stéphane Emiliani, Clarissa Berlioz-torrent, Guillaume Blot
  • Publication number: 20120022054
    Abstract: The present invention concerns novel substituted aryl derivatives, their process of preparation and their use for inhibiting virus replication and for treating viral diseases or disorders such as HIV and/or HCV infection.
    Type: Application
    Filed: December 10, 2009
    Publication date: January 26, 2012
    Applicant: LABORATOIRE BIODIM
    Inventors: Richard Benarous, Sabine Barbey-Treve, Jean-Marc Paris, Sebastien Berrut, Clarisse Berlioz-Torrent, Stephane Emiliani